PriceTargets.com logo

Neighbourly Pharmacy - NBLY Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: C$24.50
  • Forecasted Upside: 89.63%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
C$12.92 As of 09/28/2023 01:40 PM ET
▲ +0.07 (0.54%)

This chart shows the closing price for NBLY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Neighbourly Pharmacy Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NBLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NBLY

Analyst Price Target is C$24.50
▲ +89.63% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Neighbourly Pharmacy in the last 3 months. The average price target is C$24.50, with a high forecast of C$30.00 and a low forecast of C$20.00. The average price target represents a 89.63% upside from the last price of C$12.92.

This chart shows the closing price for NBLY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Moderate Buy

The current consensus among 6 investment analysts is to moderate buy stock in Neighbourly Pharmacy. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/4/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/2/2023ScotiabankLower TargetOutperformC$24.50 ➝ C$24.00
8/2/2023BMO Capital MarketsLower TargetMarket PerformC$23.00 ➝ C$21.00
8/2/2023DesjardinsLower TargetHoldC$21.00 ➝ C$20.00
7/13/2023Royal Bank of CanadaLower TargetOutperformC$34.00 ➝ C$28.00
6/9/2023National BanksharesLower TargetSector PerformC$22.00 ➝ C$20.50
6/9/2023Royal Bank of CanadaLower TargetOutperformC$35.00 ➝ C$34.00
6/9/2023TD SecuritiesLower TargetBuyC$29.00 ➝ C$28.00
6/9/2023BMO Capital MarketsLower TargetC$25.00 ➝ C$23.00
6/9/2023CormarkLower TargetC$36.00 ➝ C$30.00
6/9/2023ScotiabankLower TargetC$26.50 ➝ C$24.50
6/2/2023TD SecuritiesLower TargetBuyC$30.00 ➝ C$29.00
5/3/2023Royal Bank of CanadaLower TargetOutperformC$36.00 ➝ C$35.00
2/15/2023TD SecuritiesBoost TargetBuyC$28.00 ➝ C$30.00
2/15/2023ScotiabankLower TargetC$27.00 ➝ C$26.50
2/6/2023Royal Bank of CanadaLower TargetC$37.00 ➝ C$36.00
10/26/2022BMO Capital MarketsBoost TargetC$20.00 ➝ C$25.00
10/26/2022National BanksharesBoost TargetC$20.00 ➝ C$22.00
10/21/2022TD SecuritiesLower TargetBuyC$33.00 ➝ C$28.00
10/3/2022ScotiabankLower TargetC$35.00 ➝ C$25.00
9/23/2022BMO Capital MarketsLower TargetC$22.50 ➝ C$20.00
8/26/2022ScotiabankLower TargetC$37.00 ➝ C$35.00
8/4/2022National BanksharesLower TargetSector PerformC$26.50 ➝ C$25.00
8/3/2022Royal Bank of CanadaLower TargetOutperformC$38.00 ➝ C$37.00
8/3/2022BMO Capital MarketsLower TargetC$25.00 ➝ C$22.50
8/3/2022DesjardinsLower TargetC$26.00 ➝ C$25.00
7/29/2022National BanksharesLower TargetSector PerformC$27.00 ➝ C$26.50
7/26/2022Royal Bank of CanadaLower TargetOutperformC$42.00 ➝ C$38.00
7/20/2022TD SecuritiesLower TargetBuyC$35.00 ➝ C$33.00
6/25/2022National BanksharesLower TargetSector PerformC$28.00 ➝ C$27.00
6/25/2022BMO Capital MarketsLower TargetC$33.00 ➝ C$25.00
6/25/2022ScotiabankLower TargetC$41.00 ➝ C$37.00
6/25/2022TD SecuritiesLower TargetBuyC$39.00 ➝ C$35.00
6/8/2022National BanksharesLower TargetSector PerformC$35.00 ➝ C$28.00
4/11/2022TD SecuritiesInitiated CoverageBuyC$39.00
3/24/2022DesjardinsBoost TargetC$33.00 ➝ C$35.00
3/21/2022Royal Bank of CanadaBoost TargetOutperformC$39.00 ➝ C$42.00
3/21/2022Industrial Alliance SecuritiesUpgradeBuyC$40.00
(Data available from 9/28/2018 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/31/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2023
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/30/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/29/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Neighbourly Pharmacy logo
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: C$12.92
Low: C$12.84
High: C$13.03

50 Day Range

MA: C$15.65
Low: C$12.85
High: C$18.24

52 Week Range

Now: C$12.92
Low: C$12.69
High: C$25.50

Volume

8,011 shs

Average Volume

39,125 shs

Market Capitalization

C$577.14 million

P/E Ratio

N/A

Dividend Yield

1.28%

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Neighbourly Pharmacy?

The following Wall Street analysts have issued research reports on Neighbourly Pharmacy in the last year: BMO Capital Markets, Cormark, Desjardins, National Bankshares, Inc., Royal Bank of Canada, Scotiabank, and TD Securities.
View the latest analyst ratings for NBLY.

What is the current price target for Neighbourly Pharmacy?

7 Wall Street analysts have set twelve-month price targets for Neighbourly Pharmacy in the last year. Their average twelve-month price target is C$24.50, suggesting a possible upside of 90.7%. Cormark has the highest price target set, predicting NBLY will reach C$30.00 in the next twelve months. Desjardins has the lowest price target set, forecasting a price of C$20.00 for Neighbourly Pharmacy in the next year.
View the latest price targets for NBLY.

What is the current consensus analyst rating for Neighbourly Pharmacy?

Neighbourly Pharmacy currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for NBLY.

What other companies compete with Neighbourly Pharmacy?

Other companies that are similar to Neighbourly Pharmacy include Extendicare, Knight Therapeutics, Sienna Senior Living, Aurora Cannabis and CRH Medical. Learn More about companies similar to Neighbourly Pharmacy.

How do I contact Neighbourly Pharmacy's investor relations team?

Neighbourly Pharmacy's physical mailing address is 190 Attwell Drive, Unit 400, Toronto, ON M9W 6H8, Canada. The company's listed phone number is 416 309 9102. The official website for Neighbourly Pharmacy is neighbourlypharmacy.ca. Learn More about contacing Neighbourly Pharmacy investor relations.